Il short interest su Outlook Therapeutics Inc (NASDAQ:OTLK) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 6.81M a 5.35M. Questo rappresenta il 14.64% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Outlook Therapeutics Corp (XNAS:OTLK) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 4.17M azioni scambiate al giorno, ci vorrebbero 1.29 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|
OTLK | Outlook Therapeutics, Inc. Com | 09/15/2025 | 09/24/2025 | 14.64% | 36,567,832 | 5,354,593 | 4,166,758 | 1.29 | |
OTLK | Outlook Therapeutics, Inc. Com | 08/29/2025 | 09/10/2025 | 18.62% | 36,567,832 | 6,807,948 | 12,306,468 | 1 | |
OTLK | Outlook Therapeutics, Inc. Com | 08/15/2025 | 08/26/2025 | 7.97% | 36,567,832 | 2,915,338 | 1,405,398 | 2.07 | |
OTLK | Outlook Therapeutics, Inc. Com | 07/31/2025 | 08/11/2025 | 6.71% | 35,002,040 | 2,349,479 | 808,270 | 2.91 | |
OTLK | Outlook Therapeutics, Inc. Com | 07/15/2025 | 07/24/2025 | 5.78% | 35,002,040 | 2,023,374 | 956,161 | 2.12 | |
OTLK | Outlook Therapeutics, Inc. Com | 06/30/2025 | 07/10/2025 | 6.26% | 35,002,040 | 2,190,871 | 853,859 | 2.57 | |
OTLK | Outlook Therapeutics, Inc. Com | 06/13/2025 | 06/25/2025 | 7.83% | 35,002,040 | 2,739,054 | 836,163 | 3.28 | |
OTLK | Outlook Therapeutics, Inc. Com | 05/30/2025 | 06/10/2025 | 9.20% | 35,002,040 | 3,219,504 | 860,773 | 3.74 | |
OTLK | Outlook Therapeutics, Inc. Com | 05/15/2025 | 05/27/2025 | 12.26% | 25,716,326 | 3,153,047 | 490,611 | 6.43 | |
OTLK | Outlook Therapeutics, Inc. Com | 04/30/2025 | 05/09/2025 | 14.82% | 24,165,482 | 3,582,430 | 276,594 | 12.95 | |
OTLK | Outlook Therapeutics, Inc. Com | 04/15/2025 | 04/25/2025 | 16.54% | 24,165,482 | 3,996,180 | 401,188 | 9.96 | |
OTLK | Outlook Therapeutics, Inc. Com | 03/31/2025 | 04/09/2025 | 15.53% | 24,165,482 | 3,751,817 | 437,212 | 8.58 | |
OTLK | Outlook Therapeutics, Inc. Com | 03/14/2025 | 03/25/2025 | 16.25% | 24,165,482 | 3,926,857 | 317,167 | 12.38 | |
OTLK | Outlook Therapeutics, Inc. Com | 02/28/2025 | 03/11/2025 | 14.48% | 24,165,482 | 3,499,947 | 591,579 | 5.92 | |
OTLK | Outlook Therapeutics, Inc. Com | 02/14/2025 | 02/26/2025 | 14.59% | 24,165,482 | 3,526,317 | 665,297 | 5.3 | |
OTLK | Outlook Therapeutics, Inc. Com | 01/31/2025 | 02/11/2025 | 12.90% | 24,128,375 | 3,111,799 | 944,591 | 3.29 | |
OTLK | Outlook Therapeutics, Inc. Com | 01/15/2025 | 01/27/2025 | 13.10% | 24,128,375 | 3,160,455 | 998,933 | 3.16 | |
OTLK | Outlook Therapeutics, Inc. Com | 12/31/2024 | 01/10/2025 | 16.69% | 17,320,318 | 2,890,601 | 1,236,366 | 2.34 | |
OTLK | Outlook Therapeutics, Inc. Com | 12/13/2024 | 12/24/2024 | 21.82% | 16,070,319 | 3,506,851 | 1,758,347 | 1.99 | |
OTLK | Outlook Therapeutics, Inc. Com | 11/29/2024 | 12/10/2024 | 25.71% | 16,070,319 | 4,132,323 | 7,958,754 | 1 | |
OTLK | Outlook Therapeutics, Inc. Com | 11/15/2024 | 11/26/2024 | 21.15% | 16,070,319 | 3,398,949 | 285,418 | 11.91 | |
OTLK | Outlook Therapeutics, Inc. Com | 10/31/2024 | 11/11/2024 | 20.09% | 16,070,319 | 3,228,369 | 312,729 | 10.32 | |
OTLK | Outlook Therapeutics, Inc. Com | 10/15/2024 | 10/24/2024 | 18.60% | 16,070,319 | 2,989,293 | 207,868 | 14.38 | |
OTLK | Outlook Therapeutics, Inc. Com | 09/30/2024 | 10/09/2024 | 18.34% | 16,070,319 | 2,947,927 | 325,899 | 9.05 | |
OTLK | Outlook Therapeutics, Inc. Com | 09/13/2024 | 09/24/2024 | 15.36% | 16,070,319 | 2,468,158 | 301,723 | 8.18 | |
OTLK | Outlook Therapeutics, Inc. Com | 08/30/2024 | 09/11/2024 | 15.09% | 16,070,319 | 2,425,366 | 136,427 | 17.78 | |
OTLK | Outlook Therapeutics, Inc. Com | 07/31/2024 | 08/09/2024 | 14.67% | 15,820,320 | 2,321,399 | 191,817 | 12.1 | |
OTLK | Outlook Therapeutics, Inc. Com | 07/15/2024 | 07/24/2024 | 13.55% | 15,820,320 | 2,143,240 | 198,758 | 10.78 | |
OTLK | Outlook Therapeutics, Inc. Com | 06/28/2024 | 07/10/2024 | 12.35% | 15,820,320 | 1,954,316 | 309,401 | 6.32 | |
OTLK | Outlook Therapeutics, Inc. Com | 06/14/2024 | 06/26/2024 | 10.46% | 15,820,320 | 1,654,297 | 181,315 | 9.12 | |
OTLK | Outlook Therapeutics, Inc. Com | 05/31/2024 | 06/11/2024 | 8.47% | 19,650,636 | 1,663,753 | 280,473 | 5.93 | |
OTLK | Outlook Therapeutics, Inc. Com | 05/15/2024 | 05/24/2024 | 6.77% | 19,650,636 | 1,331,271 | 266,155 | 5 | |
OTLK | Outlook Therapeutics, Inc. Com | 04/30/2024 | 05/09/2024 | 6.44% | 19,543,494 | 1,258,619 | 216,589 | 5.81 | |
OTLK | Outlook Therapeutics, Inc. Com | 04/15/2024 | 04/24/2024 | 5.78% | 19,543,494 | 1,129,694 | 545,635 | 2.07 | |
OTLK | Outlook Therapeutics, Inc. Com | 03/28/2024 | 04/09/2024 | 7.43% | 17,829,255 | 1,325,524 | 2,930,390 | 1 | |
OTLK | Outlook Therapeutics, Inc. Com | 03/15/2024 | 03/26/2024 | 4.40% | 17,829,255 | 785,303 | 332,419 | 2.36 | |
OTLK | Outlook Therapeutics, Inc. Com | 02/29/2024 | 03/11/2024 | — | 9,257,875 | 11,642,593 | 1,192,816 | 9.76 | |
OTLK | Outlook Therapeutics, Inc. Com | 02/15/2024 | 02/27/2024 | 7.13% | 185,157,506 | 13,198,444 | 1,740,811 | 7.58 | |
OTLK | Outlook Therapeutics, Inc. Com | 01/31/2024 | 02/09/2024 | 7.33% | 185,157,506 | 13,568,305 | 3,773,099 | 3.6 | |
OTLK | Outlook Therapeutics, Inc. Com | 01/12/2024 | 01/24/2024 | 6.58% | 184,303,281 | 12,127,301 | 948,761 | 12.78 | |
OTLK | Outlook Therapeutics, Inc. Com | 12/29/2023 | 01/10/2024 | 6.13% | 184,303,281 | 11,306,587 | 2,482,721 | 4.55 | |
OTLK | Outlook Therapeutics, Inc. Com | 12/15/2023 | 12/27/2023 | 5.94% | 184,303,281 | 10,952,151 | 1,238,355 | 8.84 | |
OTLK | Outlook Therapeutics, Inc. Com | 11/30/2023 | 12/11/2023 | 8.75% | 184,290,781 | 16,126,031 | 1,757,359 | 9.18 | |
OTLK | Outlook Therapeutics, Inc. Com | 11/15/2023 | 11/27/2023 | 11.14% | 184,290,781 | 20,537,689 | 10,606,383 | 1.94 | |
OTLK | Outlook Therapeutics, Inc. Com | 10/31/2023 | 11/09/2023 | 17.38% | 184,290,781 | 32,034,765 | 19,986,496 | 1.6 | |
OTLK | Outlook Therapeutics, Inc. Com | 10/13/2023 | 10/24/2023 | 15.88% | 184,290,781 | 29,267,369 | 4,562,277 | 6.42 | |
OTLK | Outlook Therapeutics, Inc. Com | 09/29/2023 | 10/10/2023 | 14.50% | 184,290,781 | 26,715,602 | 3,012,939 | 8.87 |
In cerca di azioni più vendute allo scoperto?